{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:24:33Z","timestamp":1774085073180,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1023\/a:1005940405165","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T00:10:48Z","timestamp":1040515848000},"page":"213-218","source":"Crossref","is-referenced-by-count":45,"title":["Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination"],"prefix":"10.1007","volume":"38","author":[{"given":"Irene","family":"Slavc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Schuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Czech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes A.","family":"Hainfellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Seidl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Dieckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"159846_CR1","first-page":"492","volume":"7","author":"MC Chamberlain","year":"1994","unstructured":"Chamberlain MC: New approaches to and current treatment of leptomeningeal metastases. Curr Opin Oncol 7: 492\u2013500, 1994","journal-title":"Curr Opin Oncol"},{"key":"159846_CR2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/mpo.2950060304","volume":"6","author":"W Bleyer","year":"1979","unstructured":"Bleyer W, Poplack D: Intraventricular versus intralumbar methotrexate for central nervous leukemia: prolonged remission with the Ommaya reservoir. Med Pediatr Oncol 6: 207\u2013213, 1979","journal-title":"Med Pediatr Oncol"},{"key":"159846_CR3","first-page":"285","volume":"8","author":"D Fulton","year":"1982","unstructured":"Fulton D, Levin V, Gutin P et al.: Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors. Chemother Pharmacol 8: 285\u2013291, 1982","journal-title":"Chemother Pharmacol"},{"key":"159846_CR4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"WR Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients. Cancer 49: 759\u2013772, 1982","journal-title":"Cancer"},{"key":"159846_CR5","first-page":"6101","volume":"46","author":"JM Strong","year":"1986","unstructured":"Strong JM, Collins JM, Lester C, Poplack DG: Pharmacokinetics of intraventricular and intravenous N,N\u2032,N\u2033-Triethylenethiophosphoramide (Thiotepa) in Rhesus monkeys and humans. Cancer Res 46: 6101\u20136104, 1986","journal-title":"Cancer Res"},{"key":"159846_CR6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.410320411","volume":"32","author":"J Radcliff","year":"1992","unstructured":"Radcliff J, Packer RJ, Atkins TE, Dunin GR, Shut L, Goldwein JW, Sautton LN: Prospective study of cognitive function in children with medulloblastoma receiving whole brain radiotherapy and chemotherapy: 3 and 4 year results. Ann Neurol 32: 551\u2013555, 1992","journal-title":"Ann Neurol"},{"key":"159846_CR7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3171\/jns.1994.80.6.1004","volume":"80","author":"DL Johnson","year":"1994","unstructured":"Johnson DL, McGabe MA, Nicholson HS, Joseph AL, Getson PR, Byrne J, Brasseur C, Packer RJ, Reaman G: Quality of long-term survival in young children with medulloblastoma. J Neurosurg 80: 1004\u20131010, 1994","journal-title":"J Neurosurg"},{"key":"159846_CR8","first-page":"107","volume":"5","author":"SM Blaney","year":"1991","unstructured":"Blaney SM, Balis FM, Poplack DG: Pharmacologic approaches to the treatment of meningeal malignancy. Oncology 5: 107\u2013116, 1991","journal-title":"Oncology"},{"key":"159846_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/1040-8428(94)00147-L","volume":"20","author":"SL Berg","year":"1995","unstructured":"Berg SL, Poplack DG: Advances in the treatment of meningeal cancers. Crit Rev Oncol\/Hematol 20: 87\u201398, 1995","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"3","key":"159846_CR10","first-page":"89","volume":"65","author":"M Colvin","year":"1981","unstructured":"Colvin M, Hilton J: Pharmacology of cyclophosphamide and metabolites. Cancer Treat Rep 65(3): 89\u201395, 1981","journal-title":"Cancer Treat Rep"},{"key":"159846_CR11","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/BF00232343","volume":"2","author":"DS Alberts","year":"1984","unstructured":"Alberts DS, Einsphar JG, Struck R et al.: Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide). Invest New Drugs 2: 1411\u20131418, 1984","journal-title":"Invest New Drugs"},{"key":"159846_CR12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00179434","volume":"3","author":"U Bruntsch","year":"1985","unstructured":"Bruntsch U, Groos G, Hiller TA et al.: Phase I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345842) and limited Phase I data on mafosfamide-lysine. Invest New Drugs 3: 293\u2013296, 1985","journal-title":"Invest New Drugs"},{"key":"159846_CR13","first-page":"896","volume":"5","author":"NC Gorin","year":"1991","unstructured":"Gorin NC, Labopin M, Meloni G et al.: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. Leukemia 5: 896\u2013904, 1991","journal-title":"Leukemia"},{"key":"159846_CR14","first-page":"5932","volume":"47","author":"C Arndt","year":"1987","unstructured":"Arndt C, Colvin O. Balis F, Lester C, Johnson G, Poplack D: Intrathecal administration of 4-hydroperoxycyclophosphamide in Rhesus monkeys. Cancer Res 47: 5932\u20135934, 1987","journal-title":"Cancer Res"},{"key":"159846_CR15","first-page":"1598","volume":"34","author":"S Blaney","year":"1993","unstructured":"Blaney S, Balis F, Murphy R, Arndt C, Gillepsie A, Poplack D: A Phase I study of intrathecal mafosfamide in patients with refractory meningeal malignancy. Proc Am Assoc Cancer Res 34: 1598, 1993","journal-title":"Proc Am Assoc Cancer Res"},{"key":"159846_CR16","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-84988-6","volume-title":"Histologic Typing of Tumours of the Central Nervous System","author":"P Kleihues","year":"1993","unstructured":"Kleihues P, Burger OC, Scheithauer BW: Histologic Typing of Tumours of the Central Nervous System. Springer-Verlag, Berlin, 1993"},{"key":"159846_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/08880019709041597","volume":"14","author":"T Czech","year":"1997","unstructured":"Czech T, Reinbrecht A, Dietrich W, Hainfellner JA, Slavc I: Reversible occlusion shunt for intraventricular chemotherapy in shunt-dependent brain tumor patients. Pediat Hematol Oncol 14: 375\u2013380, 1997","journal-title":"Pediat Hematol Oncol"},{"issue":"supplA","key":"159846_CR18","first-page":"67","volume":"15","author":"J K\u00fchl","year":"1993","unstructured":"K\u00fchl J, Berthold F, Bode U, Bucsky P, Graf N, Grel A, Maass E, Bamberg M, Kaatsch P, Kleihues P, Rating D, Riehm H, S\u00f6rensen N: Preradiation chemotherapy of children with poor prognosis medulloblastoma. Am J Pediatr Hematol Oncol 15 (suppl A): 67\u201371, 1993","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"159846_CR19","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.41.11.1765","volume":"41","author":"MC Chamberlain","year":"1991","unstructured":"Chamberlain MC, Corey-Bloom J: Leptomeningeal metastases: 111Indium-DTPA CSF flow studies. Neurology 41: 1765\u20131769, 1991","journal-title":"Neurology"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005940405165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1005940405165\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005940405165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:00:13Z","timestamp":1749632413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1005940405165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":19,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["159846"],"URL":"https:\/\/doi.org\/10.1023\/a:1005940405165","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}